| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
Transcript Level |
| 3031 |
A_SariASG_c1540_g1_i1
287bp |
|
Dorsal_1b_[Operophtera_brumata] |
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0000381 |
P |
regulation of alternative mRNA splicing, via spliceosome |
| GO:0000977 |
F |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO:0001077 |
F |
DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO:0001715 |
P |
ectodermal cell fate specification |
| GO:0003677 |
F |
DNA binding |
| GO:0003682 |
F |
chromatin binding |
| GO:0003700 |
F |
DNA-binding transcription factor activity |
| GO:0003705 |
F |
DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0006351 |
P |
transcription, DNA-templated |
| GO:0006355 |
P |
regulation of transcription, DNA-templated |
| GO:0006366 |
P |
transcription by RNA polymerase II |
| GO:0006952 |
P |
defense response |
| GO:0006954 |
P |
inflammatory response |
| GO:0006955 |
P |
immune response |
| GO:0006964 |
P |
positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria |
| GO:0007249 |
P |
I-kappaB kinase/NF-kappaB signaling |
| GO:0007275 |
P |
multicellular organism development |
| GO:0007369 |
P |
gastrulation |
| GO:0007398 |
P |
ectoderm development |
| GO:0007419 |
P |
ventral cord development |
| GO:0007498 |
P |
mesoderm development |
| GO:0007501 |
P |
mesodermal cell fate specification |
| GO:0007507 |
P |
heart development |
| GO:0008063 |
P |
Toll signaling pathway |
| GO:0008354 |
P |
germ cell migration |
| GO:0008358 |
P |
maternal determination of anterior/posterior axis, embryo |
| GO:0009950 |
P |
dorsal/ventral axis specification |
| GO:0009952 |
P |
anterior/posterior pattern specification |
| GO:0009953 |
P |
dorsal/ventral pattern formation |
| GO:0010004 |
P |
gastrulation involving germ band extension |
| GO:0010629 |
P |
negative regulation of gene expression |
| GO:0010906 |
P |
regulation of glucose metabolic process |
| GO:0016015 |
F |
morphogen activity |
| GO:0031594 |
C |
neuromuscular junction |
| GO:0033256 |
C |
I-kappaB/NF-kappaB complex |
| GO:0034097 |
P |
response to cytokine |
| GO:0035006 |
P |
melanization defense response |
| GO:0035206 |
P |
regulation of hemocyte proliferation |
| GO:0038061 |
P |
NIK/NF-kappaB signaling |
| GO:0042387 |
P |
plasmatocyte differentiation |
| GO:0043565 |
F |
sequence-specific DNA binding |
| GO:0045892 |
P |
negative regulation of transcription, DNA-templated |
| GO:0045893 |
P |
positive regulation of transcription, DNA-templated |
| GO:0045944 |
P |
positive regulation of transcription by RNA polymerase II |
| GO:0048935 |
P |
peripheral nervous system neuron development |
| GO:0070379 |
F |
high mobility group box 1 binding |
| GO:0070491 |
F |
DNA-binding transcription factor binding |
|
FPKM:3.11 TPM:3.01 |
| 3032 |
A_SariASG_c15411_g1_i1
223bp |
|
|
|
FPKM:0.64 TPM:0.62 |
| 3033 |
A_SariASG_c15412_g1_i1
381bp |
|
proton-coupled_amino_acid_transporter_2_[Bombyx_mori] |
| GO:0006810 |
P |
transport |
| GO:0006865 |
P |
amino acid transport |
| GO:0015293 |
F |
symporter activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0055085 |
P |
transmembrane transport |
|
FPKM:1.43 TPM:1.38 |
| 3034 |
A_SariASG_c15415_g1_i1
236bp |
|
|
|
FPKM:6.00 TPM:5.81 |
| 3035 |
A_SariASG_c15416_g1_i1
229bp |
|
PREDICTED:_RNA-directed_DNA_polymerase_from_mobile_element_jockey-like_[Papilio_machaon] |
| GO:0003964 |
F |
RNA-directed DNA polymerase activity |
| GO:0005575 |
C |
cellular_component |
| GO:0006278 |
P |
RNA-dependent DNA biosynthetic process |
| GO:0006313 |
P |
transposition, DNA-mediated |
| GO:0016740 |
F |
transferase activity |
| GO:0016779 |
F |
nucleotidyltransferase activity |
|
FPKM:1.77 TPM:1.72 |
| 3036 |
A_SariASG_c15417_g1_i1
239bp |
|
|
|
FPKM:1.58 TPM:1.53 |
| 3037 |
A_SariASG_c15419_g1_i1
366bp |
|
ribosomal_protein_L18A_[Heliconius_melpomene_cythera] |
| GO:0003735 |
F |
structural constituent of ribosome |
| GO:0005840 |
C |
ribosome |
| GO:0006412 |
P |
translation |
| GO:0030529 |
C |
ribonucleoprotein complex |
|
FPKM:0.87 TPM:0.85 |
| 3038 |
A_SariASG_c15421_g1_i1
254bp |
|
|
|
FPKM:2.72 TPM:2.64 |
| 3039 |
A_SariASG_c15422_g1_i1
252bp |
|
|
|
FPKM:0.93 TPM:0.90 |
| 3040 |
A_SariASG_c15423_g1_i1
1956bp |
|
UDP-N-acetylglucosamine_transporter_isoform_X1_[Helicoverpa_armigera] |
| GO:0000139 |
C |
Golgi membrane |
| GO:0005351 |
F |
carbohydrate:proton symporter activity |
| GO:0005462 |
F |
UDP-N-acetylglucosamine transmembrane transporter activity |
| GO:0005515 |
F |
protein binding |
| GO:0005794 |
C |
Golgi apparatus |
| GO:0006047 |
P |
UDP-N-acetylglucosamine metabolic process |
| GO:0006810 |
P |
transport |
| GO:0008643 |
P |
carbohydrate transport |
| GO:0015788 |
P |
UDP-N-acetylglucosamine transmembrane transport |
| GO:0015992 |
P |
proton transmembrane transport |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:1990569 |
P |
UDP-N-acetylglucosamine transmembrane transport |
|
FPKM:9.12 TPM:8.84 |
| 3041 |
A_SariASG_c15423_g1_i2
2035bp |
|
UDP-N-acetylglucosamine_transporter_isoform_X1_[Helicoverpa_armigera] |
| GO:0000139 |
C |
Golgi membrane |
| GO:0005351 |
F |
carbohydrate:proton symporter activity |
| GO:0005462 |
F |
UDP-N-acetylglucosamine transmembrane transporter activity |
| GO:0005515 |
F |
protein binding |
| GO:0005794 |
C |
Golgi apparatus |
| GO:0006047 |
P |
UDP-N-acetylglucosamine metabolic process |
| GO:0006810 |
P |
transport |
| GO:0008643 |
P |
carbohydrate transport |
| GO:0015788 |
P |
UDP-N-acetylglucosamine transmembrane transport |
| GO:0015992 |
P |
proton transmembrane transport |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:1990569 |
P |
UDP-N-acetylglucosamine transmembrane transport |
|
FPKM:15.62 TPM:15.13 |
| 3042 |
A_SariASG_c15424_g1_i1
318bp |
|
|
|
FPKM:1.41 TPM:1.36 |
| 3043 |
A_SariASG_c15425_g1_i1
342bp |
|
|
|
FPKM:1.47 TPM:1.43 |
| 3044 |
A_SariASG_c15427_g1_i1
515bp |
|
|
|
FPKM:3.09 TPM:2.99 |
| 3045 |
A_SariASG_c15428_g1_i1
349bp |
|
|
|
FPKM:1.66 TPM:1.61 |
| 3046 |
A_SariASG_c15429_g1_i1
218bp |
|
|
|
FPKM:2.72 TPM:2.63 |
| 3047 |
A_SariASG_c1542_g1_i1
219bp |
|
|
|
FPKM:2.01 TPM:1.95 |
| 3048 |
A_SariASG_c15430_g1_i1
389bp |
|
|
|
FPKM:2.76 TPM:2.67 |
| 3049 |
A_SariASG_c15433_g1_i1
388bp |
|
unnamed_protein_product,_partial_[Bombyx_mori] |
|
FPKM:4.35 TPM:4.22 |
| 3050 |
A_SariASG_c15434_g1_i1
316bp |
|
|
|
FPKM:0.85 TPM:0.83 |
| 3051 |
A_SariASG_c15439_g1_i1
283bp |
|
|
|
FPKM:3.56 TPM:3.45 |
| 3052 |
A_SariASG_c15441_g1_i1
313bp |
|
|
|
FPKM:2.32 TPM:2.25 |
| 3053 |
A_SariASG_c15442_g1_i1
228bp |
|
|
|
FPKM:0.60 TPM:0.58 |
| 3054 |
A_SariASG_c15443_g1_i1
468bp |
|
|
|
FPKM:3.69 TPM:3.58 |
| 3055 |
A_SariASG_c15444_g1_i1
255bp |
|
|
|
FPKM:1.35 TPM:1.31 |
| 3056 |
A_SariASG_c15446_g1_i1
248bp |
|
|
|
FPKM:2.89 TPM:2.80 |
| 3057 |
A_SariASG_c15447_g1_i1
279bp |
|
|
|
FPKM:4.03 TPM:3.91 |
| 3058 |
A_SariASG_c15448_g1_i1
221bp |
|
phospholipid-transporting_ATPase_IA_[Helicoverpa_armigera] |
| GO:0000139 |
C |
Golgi membrane |
| GO:0000166 |
F |
nucleotide binding |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004012 |
F |
ATPase-coupled intramembrane lipid transporter activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005802 |
C |
trans-Golgi network |
| GO:0005886 |
C |
plasma membrane |
| GO:0008152 |
P |
metabolic process |
| GO:0015914 |
P |
phospholipid transport |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016787 |
F |
hydrolase activity |
| GO:0045332 |
P |
phospholipid translocation |
| GO:0046872 |
F |
metal ion binding |
| GO:0048194 |
P |
Golgi vesicle budding |
|
FPKM:2.61 TPM:2.53 |
| 3059 |
A_SariASG_c15451_g1_i1
254bp |
|
|
|
FPKM:2.27 TPM:2.20 |
| 3060 |
A_SariASG_c15454_g1_i1
321bp |
|
N-methyltryptophan_oxidase_[Yersinia_pseudotuberculosis] |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016647 |
F |
oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor |
| GO:0050131 |
F |
N-methyl-L-amino-acid oxidase activity |
| GO:0050660 |
F |
flavin adenine dinucleotide binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:0.00 TPM:0.00 |